Search Results
Found 1 results
510(k) Data Aggregation
(234 days)
T-STAT MICROVASCULAR TISSUE OXIMETER, MODEL 303
The Spectros T-Stat™ 303 Microvascular The Tissue Oximeter is intended for use as an adjunct monitor of the localized hemoglobin oxygen saturation of blood in the microvascular tissue spaces (StO2%) in infants, children, or adults at risk for reduced-flow and no-flow ischemic states.
The prospective clinical value of measurements made with the T-Stat™ Oximeter has not been demonstrated in disease states. The T-Stat™ Oximeter should not be used as the sole basis for diagnosis or therapy.
The Spectros T-Stat™ 303 Tissue Oximeter is a broadband, multiwavelength, Visible Light Spectroscopy (VLS) monitoring system for measuring the saturation of hemoglobin with oxygen in the microvascular tissue spaces (StQ2%).
The complete system consists of a disposable sensor probe connected to a software-driven electronic monitor. Data collection, analysis, and display functions are provided by the monitor. Illumination of the tissue is provided by a visible light source in the sensor probe placed near, on, or into the target tissue to be studied. Reflected light is captured and returned to the monitor via a detachable connection at the monitor end of the patient probe. StO2% is estimated using differential optical diffuse reflectance spectroscopy and fitting for background scattering over a range of reflected visible wavelengths.
The Spectros T-Stat™ 303 Microvascular Tissue Oximeter's acceptance criteria are not explicitly stated in the provided text as numerical thresholds for performance metrics. Instead, the document describes the device's performance in comparison to predicate devices and previously published studies to establish substantial equivalence.
Here's an analysis of the provided information, structured around your request:
1. Table of Acceptance Criteria and Reported Device Performance
As specific acceptance criteria (e.g., "accuracy must be > 90%") are not detailed, this table will reflect the comparative performance statements provided in the submission.
Performance Aspect | Acceptance Criteria (Implied) | Reported Device Performance |
---|---|---|
Hemoglobin Spectra & Desaturation Binding Curves | Accurate measurement | Accurately measured in peer-reviewed in vitro studies. |
Bias against NIRS Predicates (StO2%) | Unbiased | -1% ± 5% (p=N.S.) when compared to NIRS predicates. |
Range of Normal (StO2%) | Tighter range than NIRS predicates | 62-75% for VLS vs. 48-88% for NIRS (p |
Ask a specific question about this device
Page 1 of 1